Multiple Sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells are damaged. Microglia cells (orange) attack the oligodendrocytes that form the insulating myelin ...

Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin sheath. This further causes a lot of neurological symptoms, such as ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also ...

(RTTNews) - Quantum BioPharma Ltd. (QNTM) announced the completion of its Phase 1 clinical trial for Lucid-21-302 or Lucid-MS, an experimental drug designed to treat multiple sclerosis. The trial ...

Multiple sclerosis can cause neurological changes like weakness and decreased coordination and balance. Changes in the way your body moves may increase the risk of conditions like plantar fasciitis.

From Christina Applegate to Selma Blair to Jack Osbourne, these celebrities have been candid about their journeys with multiple sclerosis Charley Gallay/Getty; Matt Winkelmeyer/Getty; JC Olivera ...

Researchers identify enzymes ceramide synthase 5 and 6 as key players in how saturated fats worsen multiple sclerosis symptoms. Study: Neuroprotective effect of neuron-specific deletion of the C16 ...

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary ...

Multiple sclerosis (MS) is a chronic autoimmune disease — one in which the body erroneously attacks itself — that affects the central nervous system. Specifically, MS develops when the immune ...

This section presents the 2018 AAN Guideline on Disease-Modifying Therapies for Adults with Multiple Sclerosis and the 2018 European Committee for Treatment and Research in Multiple Sclerosis ...